Galectin-3 and the skin

Larissa N Larsen, Huan Yuan Chen, Jun Saegusa, Fu-Tong Liu

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Galectin-3 is highly expressed in epithelial cells including keratinocytes and is involved in the pathogenesis of inflammatory skin diseases by affecting the functions of immune cells. For example, galectin-3 can contribute to atopic dermatitis (AD) by promoting polarization toward a Th2 immune response by regulating dendritic cell (DC) and T cell functions. In addition, galectin-3 may be involved in the development of contact hypersensitivity by regulating the migratory capacity of antigen presenting cells. Galectin-3 may act as a regulator of epithelial tumor progression and development through various signaling pathways, such as inhibiting keratinocyte apoptosis through regulation of the activation status of extracellular signal-regulated kinase (ERK) and activated protein kinase B (AKT). Galectin-3 is detected at different stages of melanoma development. In contrast, a marked decrease in the expression of galectin-3 is observed in non-melanoma skin cancers, such as squamous cell carcinoma (SCC) and basal cell carcinoma (BCC). Galectin-3 may play an important role in tumor cell growth, apoptosis, cell motility, invasion, and metastasis. Galectin-3 may be a novel therapeutic target for a variety of skin diseases.

Original languageEnglish (US)
Pages (from-to)85-91
Number of pages7
JournalJournal of Dermatological Science
Volume64
Issue number2
DOIs
StatePublished - Nov 2011

Fingerprint

Galectin 3
Skin
Keratinocytes
Skin Diseases
Tumors
Apoptosis
Proto-Oncogene Proteins c-akt
T-cells
Basal Cell Carcinoma
Contact Dermatitis
Extracellular Signal-Regulated MAP Kinases
Cell growth
Skin Neoplasms
Antigen-Presenting Cells
Atopic Dermatitis
Dendritic Cells
Cell Movement
Squamous Cell Carcinoma
Melanoma
Neoplasms

Keywords

  • Galectins
  • Lectins
  • Skin cancer
  • Skin inflammation

ASJC Scopus subject areas

  • Dermatology
  • Biochemistry
  • Molecular Biology

Cite this

Galectin-3 and the skin. / Larsen, Larissa N; Chen, Huan Yuan; Saegusa, Jun; Liu, Fu-Tong.

In: Journal of Dermatological Science, Vol. 64, No. 2, 11.2011, p. 85-91.

Research output: Contribution to journalArticle

Larsen, Larissa N ; Chen, Huan Yuan ; Saegusa, Jun ; Liu, Fu-Tong. / Galectin-3 and the skin. In: Journal of Dermatological Science. 2011 ; Vol. 64, No. 2. pp. 85-91.
@article{7be880626f1846dbafff7f28ad9f9fa8,
title = "Galectin-3 and the skin",
abstract = "Galectin-3 is highly expressed in epithelial cells including keratinocytes and is involved in the pathogenesis of inflammatory skin diseases by affecting the functions of immune cells. For example, galectin-3 can contribute to atopic dermatitis (AD) by promoting polarization toward a Th2 immune response by regulating dendritic cell (DC) and T cell functions. In addition, galectin-3 may be involved in the development of contact hypersensitivity by regulating the migratory capacity of antigen presenting cells. Galectin-3 may act as a regulator of epithelial tumor progression and development through various signaling pathways, such as inhibiting keratinocyte apoptosis through regulation of the activation status of extracellular signal-regulated kinase (ERK) and activated protein kinase B (AKT). Galectin-3 is detected at different stages of melanoma development. In contrast, a marked decrease in the expression of galectin-3 is observed in non-melanoma skin cancers, such as squamous cell carcinoma (SCC) and basal cell carcinoma (BCC). Galectin-3 may play an important role in tumor cell growth, apoptosis, cell motility, invasion, and metastasis. Galectin-3 may be a novel therapeutic target for a variety of skin diseases.",
keywords = "Galectins, Lectins, Skin cancer, Skin inflammation",
author = "Larsen, {Larissa N} and Chen, {Huan Yuan} and Jun Saegusa and Fu-Tong Liu",
year = "2011",
month = "11",
doi = "10.1016/j.jdermsci.2011.07.008",
language = "English (US)",
volume = "64",
pages = "85--91",
journal = "Journal of Dermatological Science",
issn = "0923-1811",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Galectin-3 and the skin

AU - Larsen, Larissa N

AU - Chen, Huan Yuan

AU - Saegusa, Jun

AU - Liu, Fu-Tong

PY - 2011/11

Y1 - 2011/11

N2 - Galectin-3 is highly expressed in epithelial cells including keratinocytes and is involved in the pathogenesis of inflammatory skin diseases by affecting the functions of immune cells. For example, galectin-3 can contribute to atopic dermatitis (AD) by promoting polarization toward a Th2 immune response by regulating dendritic cell (DC) and T cell functions. In addition, galectin-3 may be involved in the development of contact hypersensitivity by regulating the migratory capacity of antigen presenting cells. Galectin-3 may act as a regulator of epithelial tumor progression and development through various signaling pathways, such as inhibiting keratinocyte apoptosis through regulation of the activation status of extracellular signal-regulated kinase (ERK) and activated protein kinase B (AKT). Galectin-3 is detected at different stages of melanoma development. In contrast, a marked decrease in the expression of galectin-3 is observed in non-melanoma skin cancers, such as squamous cell carcinoma (SCC) and basal cell carcinoma (BCC). Galectin-3 may play an important role in tumor cell growth, apoptosis, cell motility, invasion, and metastasis. Galectin-3 may be a novel therapeutic target for a variety of skin diseases.

AB - Galectin-3 is highly expressed in epithelial cells including keratinocytes and is involved in the pathogenesis of inflammatory skin diseases by affecting the functions of immune cells. For example, galectin-3 can contribute to atopic dermatitis (AD) by promoting polarization toward a Th2 immune response by regulating dendritic cell (DC) and T cell functions. In addition, galectin-3 may be involved in the development of contact hypersensitivity by regulating the migratory capacity of antigen presenting cells. Galectin-3 may act as a regulator of epithelial tumor progression and development through various signaling pathways, such as inhibiting keratinocyte apoptosis through regulation of the activation status of extracellular signal-regulated kinase (ERK) and activated protein kinase B (AKT). Galectin-3 is detected at different stages of melanoma development. In contrast, a marked decrease in the expression of galectin-3 is observed in non-melanoma skin cancers, such as squamous cell carcinoma (SCC) and basal cell carcinoma (BCC). Galectin-3 may play an important role in tumor cell growth, apoptosis, cell motility, invasion, and metastasis. Galectin-3 may be a novel therapeutic target for a variety of skin diseases.

KW - Galectins

KW - Lectins

KW - Skin cancer

KW - Skin inflammation

UR - http://www.scopus.com/inward/record.url?scp=80053385529&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053385529&partnerID=8YFLogxK

U2 - 10.1016/j.jdermsci.2011.07.008

DO - 10.1016/j.jdermsci.2011.07.008

M3 - Article

C2 - 21889881

AN - SCOPUS:80053385529

VL - 64

SP - 85

EP - 91

JO - Journal of Dermatological Science

JF - Journal of Dermatological Science

SN - 0923-1811

IS - 2

ER -